Restarting an antidepressant
Restarting, or reinstating, an antidepressant means going back to a medication you stopped, or back to a higher dose you were on. Common reasons are withdrawal symptoms that are too hard to manage, or depression or anxiety coming back. The two can be hard to tell apart, and what happens next depends on which it is.
Also called: Reinstatement, Reinstating an antidepressant, Going back up a dose.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
When is restarting an antidepressant used?
Most often when withdrawal symptoms after a stop or a cut are more than you can carry. The US label for Lexapro says it plainly: if intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered.
It is also used when depression itself looks to be coming back. That is a different reason, and it leads to a different conversation with your prescriber about which dose and for how long.
How soon does restarting help?
Withdrawal symptoms often ease within days of the previous dose being back. That speed is one of the things prescribers use to tell withdrawal apart from a relapse, which builds over weeks and does not lift within days of a dose change.
It is not that fast for everyone. A 2025 systematic review of withdrawal symptoms that run on for months found no reliable evidence that restarting the medication helps in those cases, so slow improvement on its own does not show that the depression is back. No trial has timed how fast reinstatement works, so the few days is clinical experience rather than a figure. If symptoms do not settle, tell your prescriber instead of waiting it out.
Working out which of the two it is matters for what comes next. Horowitz and Taylor wrote in The Lancet Psychiatry in 2019 that withdrawal can be mistaken for the illness returning, which can leave someone on a medication for longer than the plan needed, and that is a question to take to your prescriber rather than settle alone.
What does the restart dose depend on?
On which medication you take, how far down you had come and how long you were off it. Those are the things your prescriber weighs, and they are also what to bring to the appointment, with dates.
The reduction that follows a restart is usually slower and in smaller steps than the one before it. A 2015 review of discontinuation symptoms found general consensus on tapering slowly, over weeks or months, for coming off in general, and for severe symptoms it says the drug should be reinstated and then discontinued more gradually. Steps that shrink in milligrams as the dose falls are what hyperbolic tapering means, and that term has its own page.
How long to hold the restarted dose before trying another reduction is the next question, and there is no set figure for it. Agree with your prescriber what has to settle first and when you will look at it again.
What to do
If withdrawal symptoms are hard to bear, contact your prescriber rather than restarting on your own. Tell them which dose you were on, when you changed it and when each symptom began, and ask how long to stay on the restarted dose before the next reduction. If you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
Plan smaller steps for after a restart
How withClaro helps
- Your doses and symptoms on one timeline
- A PDF report to share with your prescriber before the next step
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- Wilson E, Lader M. A review of the management of antidepressant discontinuation symptoms. Therapeutic Advances in Psychopharmacology, 2015.
- Framer A. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology, 2021.
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 2019.
- Rennwald A, Hengartner MP. Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis. Epidemiology and Psychiatric Sciences, 2025.
All glossary terms